{
    "2018-08-24": [
        [
            {
                "time": "",
                "original_text": "【西南医药朱国广团队】国药一致（000028）分销业务保持稳健，零售盈利能力大幅提升",
                "features": {
                    "keywords": [
                        "国药一致",
                        "分销业务",
                        "零售",
                        "盈利能力",
                        "大幅提升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "零售",
                        "分销"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]国药一致(000028)半年报点评：分销业务保持稳健 零售盈利能力大幅提升",
                "features": {
                    "keywords": [
                        "买入评级",
                        "国药一致",
                        "半年报",
                        "分销业务",
                        "零售",
                        "盈利能力",
                        "大幅提升"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "零售",
                        "分销"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}